Inventor · disambiguated record
Sabine Sewing
Also filed as: SEWING SABINE
5 granted patents·7 pending applications·1 citations·filing 2011–2025
64Inventor score
Top patents by PatentIndex Score
12 records- 0174US11105794B2In vitro nephrotoxicity screening assayHOFFMANN LA ROCHE·Filed 2017·Granted Aug 31, 2021·1 cites·21 claims
- 0270US2024182898A1ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSIONHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0368US11898145B2Enhanced oligonucleotides for inhibiting RTEL1 expressionHOFFMANN LA ROCHE·Filed 2022·Granted Feb 13, 2024·0 cites·17 claims
- 0462US2021405027A1In vitro nephrotoxicity screening assayHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0559US2024167040A1Antisense oligonucleotideHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0653US2021349076A1In vitro toxicity screening assayROCHE INNOVATION CT COPENHAGEN AS·Filed 2021·Application pending·0 cites
- 0749US2022031730A1Enhanced oligonucleotides for modulating fubp1 expressionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0847US10955407B2In vitro toxicity screening assayROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Mar 23, 2021·0 cites·16 claims
- 0945US2025376684A1Threose nucleic acid antisense oligonucleotides and methods thereofHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1043US2013345201A1Pharmaceutical combinationHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1141US10815481B2Chiral library screenROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Granted Oct 27, 2020·0 cites·14 claims
- 1240US9132136B2Pharmaceutical combinationHOENER MARIUS·Filed 2011·Granted Sep 15, 2015·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →